Oncology Pharma Downside Deviation
| ONPH Pink Sheet | | | USD 0.07 0.0002 0.29% |
Downside Deviation data for Oncology Pharma is presented below, including the current value, historical progression, and peer context. Signal strength depends on data continuity and the instrument's typical trading volume. The pairing of
Oncology Pharma Volatility and
Oncology Pharma Price History broadens the analytical view on Oncology Pharma.
Current Downside Deviation Value
Oncology Pharma carries a Downside Deviation of 26.95, consistent with elevated price variability. This places Oncology Pharma toward the higher end of the volatility range for Pink Sheet.
Downside Deviation | = | SQRT(DV) |
| = | 26.95 | |
Downside Deviation Peers Comparison
Downside Deviation Relative To Other Indicators
The chart below plots Downside Deviation against Maximum Drawdown for Oncology Pharma and its peers. Each point represents one equity — position along the horizontal axis shows Downside Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
At
26.95 for Downside Deviation and
202.12 for Maximum Drawdown, Oncology Pharma's cross-indicator ratio sits almost
7.50 . This indicates Maximum Drawdown substantially exceeds Downside Deviation for Oncology Pharma.
Methodology, Assumptions & Data Sources
The current Downside Deviation for Oncology Pharma is 26.95. Downside Deviation for Oncology Pharma is derived by applying a defined formula to historical price observations, producing a time-series of comparable readings. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. Indicator accuracy depends on data continuity across the calculation period. Gaps in trading history may affect the output.
Other Technical Indicators